Senators question Allergan CEO on tribe patent deal
Descrição
A group of five senators said the deal was a "blatant attempt to further Allergan's market monopoly" on its $1.5 billion eye drug, Restasis.
Patent transfer to Mohawk tribe intended to stop generic drugs
Selling Sovereignty: How Corporations Used Tribal Sovereign Immunity to Evade Regulation and Exploit Consumers - The Flaw
Allergan does patent deal for Restasis with Native American tribe
Durotep MT, Radio Compass Blog, Latest Pharmaceutical Articles
Patent transfer to Mohawk tribe intended to stop generic drugs
Allergan plc
Senators question Allergan CEO on tribe patent deal
Judge asks if Allergan's patent deal with Mohawk tribe is a 'sham
Selling Sovereignty: How Corporations Used Tribal Sovereign Immunity to Evade Regulation and Exploit Consumers - The Flaw
/cdn.vox-cdn.com/uploads/chorus_asset/file/10043135/GettyImages_633171470.jpg)
Trump's abandoned promise to bring down drug prices, explained - Vox
All eyes on Saint Regis Mohawk Tribe in contentious patent case
DuetsBlog ® Creativity & the Law
Supreme Court case could deal a blow to Mohawk tribe's patent plan
de
por adulto (o preço varia de acordo com o tamanho do grupo)
